Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The acclaimed Switching Perceptions exhibition, showing artwork and concepts which were created in collaboration with people experiencing psychosis, will be on show at the Barbican.

From Segment of aself, artwork © Eleanor Minney, 2018

From 12 to 20 October 2019 in the Life Rewired Hub at the Barbican, a series of events, workshops and talks that consider whether an understanding of our genes could lead to a better understanding of mental illness will take place.

Created by artist Eleanor Minney and Associate Professor Liz Tunbridge, Department of Psychiatry, University of Oxford, in collaboration with patients from the National Psychosis Unit at the Bethlem Royal Hospital, the project will allow visitors to explore perspectives on the mind, brain, subjective experience and the genetic and biological components of psychiatric illness.

For further event information visit Barbican.

The original exhibition took place at the Bethlem Gallery from Jan-March 2019.

Winner of the Vice-Chancellor's Public Engagement Award - engaging through art in psychiatric illnesses.

Read more in The Conversation - How the power of art can help scientists like me understand the experience of schizophrenia.

NIHR OXFORD HEALTH BIOMEDICAL RESEARCH CENTRE NEWS

Please follow the link below to read the news on the NIHR BRC website.

Similar stories

Just Over Half of British Indians Would Get COVID Vaccine

COVID-19 Mental Health

University of Oxford researchers from the Department of Physiology, Anatomy and Genetics (DPAG) and the Department of Psychiatry, in collaboration with The 1928 Institute, have published a major new study on the impact of COVID-19 on the UK’s largest BME population.

Investigating New Treatment for Schizophrenia

Mental Health Schizophrenia

A partnership between University of Oxford, the Earlham Institute, and the global pharmaceutical companies Biogen Inc and Boehringer Ingelheim is announced today to investigate a new drug target for the treatment of schizophrenia.

Parental Mental Health Worse Since New National Restrictions

COVID-19 Child and adolescent Early intervention Mental Health Psychological therapy

Parental stress, depression, and anxiety have again increased since new national restrictions have been introduced according to the latest report from the Oxford University led COVID-19 Supporting Parents, Adolescents, and Children in Epidemics (Co-SPACE) study based on data from over 6000 UK parents.

Potential New Target to Prevent or Delay Dementia

Alzheimer's disease Dementia Mental Health Old-age psychiatry

New study shows targeting arterial stiffening earlier in a person’s lifespan could provide cognitive benefits in older age and may help to delay the onset of dementia.

SSRI Treatment in Young People with Depression and Anxiety

Anxiety Depression Mental Health

Results from an insight review commissioned by the Wellcome Trust, highlights what is currently known about the benefits and risks of using selective serotonin reuptake inhibitors (SSRIs) for the treatment of depression and anxiety in young people.

Collaborating with Youth is Key to Studying Mental Health Management

Anxiety Depression Mental Health

The Global Mental Health Databank, a feasibility study, hopes to enable youth from the United Kingdom, South Africa, and India to work directly with mental health researchers to better understand how young people can manage their own mental health.